Developments in pharmacological therapy for the overactive bladder

被引：9
|
作者：
Chapple, Christopher R.
Gormley, E. Ann
机构：
[1] Sheffield Hallam Univ, Dept Urol, Sheffield Teaching Hosp, NHS Fdn Trust, Sheffield 510 2JF, S Yorkshire, England
[2] Dartmouth Hitchcock Med Ctr, Sect Urol, Lebanon, NH USA
来源：
BJU INTERNATIONAL | 2006年 / 98卷
关键词：
overactive bladder; pharmacotherapy; detrusor overactivity; cholinergic-muscarinic receptors; adrenoceptor; agonist; antagonist; anticholinergics; vanilloids; botulinum toxin; RAT URINARY-BLADDER; QUALITY-OF-LIFE; DETRUSOR SMOOTH-MUSCLE; ANTIMUSCARINIC AGENT SOLIFENACIN; SELECTIVE RECEPTOR ANTAGONIST; EXTENDED-RELEASE FORMULATIONS; CARBACHOL-INDUCED CONTRACTION; BOTULINUM-TOXIN; CONTROLLED TRIAL; AUTONOMOUS ACTIVITY;
D O I：
10.1111/j.1464-410X.2006.06381.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：78 / 87
页数：10
相关论文
共 50 条
  • [41] Medical Therapy in Overactive Bladder of the Elderly
    Bayrak O.
    Mock S.
    Dmochowski R.R.
    Current Bladder Dysfunction Reports, 2014, 9 (4) : 326 - 335
  • [42] The evolution of transdermal therapy for overactive bladder
    Sand P.K.
    Current Urology Reports, 2009, 10 (5) : 338 - 341
  • [43] Pharmacological agents for the treatment of urinary incontinence due to overactive bladder
    Wein, AJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (01) : 65 - 83
  • [44] Rho kinase - a new target for pharmacological treatment of an overactive bladder
    Wrobel, Andrzej
    Adamiak, Aneta
    Skorupski, Pawel
    Rechberger, Tomasz
    GINEKOLOGIA POLSKA, 2008, 79 (05) : 364 - 369
  • [45] CNS involvement in overactive bladder - Pathophysiology and opportunities for pharmacological intervention
    Andersson, KE
    Pehrson, R
    DRUGS, 2003, 63 (23) : 2595 - 2611
  • [46] New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
    Andersson, Karl-Erik
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 161 - 170
  • [47] Systematic review of therapy for men with overactive bladder
    Chapple, Christopher
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (03): : S143 - S145
  • [48] Combination Therapy for Overactive Bladder: Who Approves?
    Staskin, David R.
    EUROPEAN UROLOGY, 2018, 74 (04) : 510 - 511
  • [49] The management of overactive bladder refractory to medical therapy
    Robinson, Dudley
    Giarenis, Ilias
    Cardozo, Linda
    MATURITAS, 2013, 75 (01) : 101 - 104
  • [50] Anticholinergic therapy for overactive bladder: A nicotinic modality?
    Toler, Steven M.
    Yohannes, Daniel
    Lippiello, Patrick M.
    Chancellor, Michael B.
    MEDICAL HYPOTHESES, 2013, 81 (03) : 456 - 458
12345